A study into the anti-tumor effects of specific nutrients has led to positive results. A unique amino acids-plus formulation of lysine, proline, arginine, ascorbic acid, and epigallocatechin gallate was proved to have anticancer properties, and could become a natural anticancer agent to treat prostate cancer. 

Prostate cancer is the most common cancer among men, after skin cancer. In fact, about 1 man in 6 will be diagnosed with prostate cancer (U.S. data). But prostate cancer can often be treated successfully, especially if detected early.

Prostate cancer can often be found by testing for a prostate-specific antigen in the blood. A digital rectal exam is also a common screening technique. Once diagnosed and staged, prostate cancer can be treated with surgery, radiation therapy, cryotherapy, chemotherapy, hormone therapy, and other treatments.

Because some treatments, like chemotherapy, have severe side effects, scientists worldwide are studying new, non-toxic anti-cancer therapies, including some amino acids.

Amino acids nutrient study results: proliferation of prostate cancer cells reduced

Researchers Roomi MW, Ivanov V, et al, from the Matthias Rath Research, Cancer Division, Santa Clara, USA, developed a unique formula containing specific amino acids to treat prostate cancer cell lines.

Various concentrations of the amino acids lysine, proline, and arginine, were combined with ascorbic acid and epigallocatechin gallate. This mixture was tested on prostate cancer cell lines in vitro. The proliferation, or growth, of prostate cancer cells was measured.

Lysine is one of the essential amino acids, which means we must ingest it since our bodies cannot produce it by themselves. The two amino acids proline and arginine are synthesized in our bodies, though of course all amino acids can be consumed as supplements or can come from eating certain protein foods, including meats.

Results of the study were impressive. The amino acids-plus mixture produced a dose-dependent inhibition of some of the prostate cancer cell lines. The researchers concluded that the lysine, proline, and arginine amino acids, ascorbic acid, and epigallocatechin gallate mixture could become a potent anticancer agent, and could be a new treatment for prostate cancer.